Published in Alcohol Clin Exp Res on March 22, 2007
Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol (2007) 3.06
Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem Pharmacol (2007) 2.18
Neuroscience of behavioral and pharmacological treatments for addictions. Neuron (2011) 1.57
Cognitive enhancement as a treatment for drug addictions. Neuropharmacology (2012) 1.54
Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacol Biochem Behav (2011) 1.38
A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. Am J Addict (2009) 1.35
Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology (Berl) (2010) 1.29
Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias. Clin Interv Aging (2009) 1.14
Glutamatergic targets for new alcohol medications. Psychopharmacology (Berl) (2013) 1.10
Open-label memantine in fragile X syndrome. J Autism Dev Disord (2009) 1.04
Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav (2011) 1.00
D-Serine and D-Cycloserine Reduce Compulsive Alcohol Intake in Rats. Neuropsychopharmacology (2015) 0.98
Ethanol-like effects of thiopental and ketamine in healthy humans. J Psychopharmacol (2008) 0.97
Effects of topiramate and other anti-glutamatergic drugs on the acute intoxicating actions of ethanol in mice: modulation by genetic strain and stress. Neuropsychopharmacology (2008) 0.95
Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawal. Br J Pharmacol (2011) 0.94
Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependence. Neuropsychopharmacology (2010) 0.89
Pharmacologic dissociation between impulsivity and alcohol drinking in high alcohol preferring mice. Alcohol Clin Exp Res (2010) 0.87
Pharmacological approaches to reducing craving in patients with alcohol use disorders. CNS Drugs (2014) 0.86
The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis. Pharmacol Rev (2016) 0.86
Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication. Subst Abuse Treat Prev Policy (2008) 0.85
Placebo group improvement in trials of pharmacotherapies for alcohol use disorders: a multivariate meta-analysis examining change over time. J Clin Psychopharmacol (2013) 0.84
Future pharmacological treatments for substance use disorders. Br J Clin Pharmacol (2014) 0.83
Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry (2015) 0.83
History of dating violence and the association with late adolescent health. BMC Public Health (2013) 0.81
Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders. J Subst Abuse Treat (2011) 0.81
N-methyl-D-aspartate receptor antagonism has differential effects on alcohol craving and drinking in heavy drinkers. Alcohol Clin Exp Res (2015) 0.81
Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models. Addict Biol (2016) 0.80
Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders. CNS Neurol Disord Drug Targets (2015) 0.80
Dating violence victimization across the teen years: abuse frequency, number of abusive partners, and age at first occurrence. BMC Public Health (2012) 0.80
"Killing Two Birds with One Stone": Alcohol Use Reduction Interventions with Potential Efficacy in Enhancing Self-Control. Curr Addict Rep (2014) 0.79
NMDA Receptor Modulators in the Treatment of Drug Addiction. Pharmaceuticals (Basel) (2013) 0.77
Addicted to palatable foods: comparing the neurobiology of Bulimia Nervosa to that of drug addiction. Psychopharmacology (Berl) (2014) 0.77
The Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking and Relapse with Low Side-Effect Profile. Neuropsychopharmacology (2015) 0.76
Pharmacotherapy for alcohol use disorder: current and emerging therapies. Harv Rev Psychiatry (2015) 0.76
Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective. F1000Res (2017) 0.75
Interactions of a Dopamine D1 Receptor Agonist with Glutamate NMDA Receptor Antagonists on the Volitional Consumption of Ethanol by the mHEP Rat. Pharmaceuticals (Basel) (2013) 0.75
Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder. Neurosci Biobehav Rev (2017) 0.75
Do specific NMDA receptor subunits act as gateways for addictive behaviors? Genes Brain Behav (2016) 0.75
NMDA glutamate receptor antagonism and the heritable risk for alcoholism: new insights from a study of nitrous oxide. Int J Neuropsychopharmacol (2017) 0.75
Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA (2004) 4.12
Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend (2011) 1.62
Variations in nanomechanical properties and tissue composition within trabeculae from an ovine model of osteoporosis and treatment. Bone (2012) 1.60
Treatment of cannabis use disorders: a review of the literature. Am J Addict (2007) 1.48
Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend (2006) 1.42
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry (2004) 1.39
A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. Am J Addict (2009) 1.35
A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend (2005) 1.31
Oxygen-controlled three-dimensional cultures to analyze tumor angiogenesis. Tissue Eng Part A (2010) 1.24
Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial. Biol Psychiatry (2012) 1.18
Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo. Drug Alcohol Depend (2005) 1.18
Treatment of depression in patients with opiate dependence. Biol Psychiatry (2004) 1.16
Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. Drug Alcohol Depend (2010) 1.15
Psychostimulant treatment of cocaine dependence. Psychiatr Clin North Am (2012) 1.12
Management of relapse in naltrexone maintenance for heroin dependence. Drug Alcohol Depend (2007) 1.11
Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Schizophr Res (2013) 1.10
Mindfulness impairments in individuals seeking treatment for substance use disorders. Am J Drug Alcohol Abuse (2011) 1.10
Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol Depend (2005) 1.08
Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder). Horm Behav (2008) 1.06
Utility of lead-in period in cocaine dependence pharmacotherapy trials. Drug Alcohol Depend (2005) 1.06
Training physicians to treat substance use disorders. Curr Psychiatry Rep (2008) 1.06
The emerging role of meditation in addressing psychiatric illness, with a focus on substance use disorders. Harv Rev Psychiatry (2009) 1.05
Evaluation of a combined online and in person training in the use of buprenorphine. Subst Abus (2006) 1.04
Adult ADHD and substance abuse: diagnostic and treatment issues. Subst Use Misuse (2005) 1.04
Uses of coercion in addiction treatment: clinical aspects. Am J Addict (2008) 1.04
Parylene peel-off arrays to probe the role of cell-cell interactions in tumour angiogenesis. Integr Biol (Camb) (2009) 1.02
Alcohol increases impulsivity and abuse liability in heavy drinking women. Exp Clin Psychopharmacol (2012) 1.02
A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period. Drug Alcohol Depend (2010) 1.01
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. Addiction (2013) 1.01
Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. Addiction (2012) 1.00
Acute interaction of baclofen in combination with alcohol in heavy social drinkers. Alcohol Clin Exp Res (2008) 1.00
Course of weight change during naltrexone versus methadone maintenance for opioid-dependent patients. J Opioid Manag (2011) 0.98
Attention-deficit/hyperactivity disorder and early-onset substance use disorders. J Child Adolesc Psychopharmacol (2005) 0.97
Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence. J Subst Abuse Treat (2007) 0.96
Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder. J Addict Dis (2002) 0.95
Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement. Drug Alcohol Depend (2012) 0.94
Response to alcohol in females with a paternal history of alcoholism. Psychopharmacology (Berl) (2003) 0.94
Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction (2013) 0.92
Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans. Psychopharmacology (Berl) (2011) 0.92
Dextromethorphan and quinidine combination for heroin detoxification. Am J Addict (2008) 0.92
Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade? Drug Alcohol Depend (2013) 0.92
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence. Drug Alcohol Depend (2011) 0.92
Effects of alternative reinforcer and craving on the choice to smoke cigarettes in the laboratory. Hum Psychopharmacol (2007) 0.89
Treatment of Co-occurring Depression and Substance Dependence: Using Meta-analysis to Guide Clinical Recommendations. Psychiatr Ann (2008) 0.89
Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol. Drug Alcohol Depend (2009) 0.89
Unobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trial. Addict Behav (2010) 0.89
The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population. Int J Methods Psychiatr Res (2013) 0.89
Treating nicotine dependence by targeting attention-deficit/ hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment response. J Clin Psychiatry (2013) 0.88
Combined effects of botulinum toxin injection and hind limb unloading on bone and muscle. Calcif Tissue Int (2013) 0.88
Treating depression in substance abusers. Curr Psychiatry Rep (2006) 0.87
Treatment strategies for co-occurring ADHD and substance use disorders. Am J Addict (2007) 0.87
Response to alcohol in women: role of the menstrual cycle and a family history of alcoholism. Drug Alcohol Depend (2011) 0.87
Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcome. Am J Drug Alcohol Abuse (2006) 0.87
Severity of dependence and motivation for treatment: comparison of marijuana- and cocaine-dependent treatment seekers. J Addict Dis (2006) 0.86
The effects of progesterone pretreatment on the response to oral d-amphetamine in Women. Horm Behav (2010) 0.86
Electrical control of cell density gradients on a conducting polymer surface. Chem Commun (Camb) (2009) 0.86
Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend (2013) 0.86
Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia. Am J Addict (2007) 0.85
Predictors of treatment contact among individuals with cannabis dependence. Am J Drug Alcohol Abuse (2004) 0.85
Pediatric obesity: parallels with addiction and treatment recommendations. Harv Rev Psychiatry (2008) 0.85
Antiretroviral medication: an emerging category of prescription drug misuse. Am J Addict (2013) 0.84
Predictors of cannabis dependence recovery among epidemiological survey respondents in the United States. Am J Drug Alcohol Abuse (2007) 0.84
Does Attention Deficit Hyperactivity Disorder increase the risk of suicide attempts? J Affect Disord (2011) 0.83
Screening and intervention for alcohol and illicit drug abuse:a survey of internal medicine housestaff. J Addict Dis (2005) 0.83
A comparison of psychosocial and cognitive functioning between depressed and non-depressed patients with cannabis dependence. J Addict Dis (2010) 0.83
Early abstinence in cocaine dependence: influence of comorbid major depression. Am J Addict (2007) 0.83
A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers. Am J Addict (2011) 0.82
Smoking and psychopathology increasingly associated in recent birth cohorts. Drug Alcohol Depend (2013) 0.82
Effect of bisphosphonates on the rapidly growing male murine skeleton. Endocrinology (2014) 0.81
Quantifying the dependence of dead lithium losses on the cycling period in lithium metal batteries. Phys Chem Chem Phys (2014) 0.81
Assessment of cognitive functioning of methadone-maintenance patients: impact of adult ADHD and current cocaine dependence. J Addict Dis (2006) 0.81
Distinct types of microglial activation in white and grey matter of rat lumbosacral cord after mid-thoracic spinal transection. J Neuropathol Exp Neurol (2007) 0.81
Socially sanctioned coercion mechanisms for addiction treatment. Am J Addict (2007) 0.81
Pharmacotherapy for alcohol-related disorders: what clinicians should know. Harv Rev Psychiatry (2005) 0.81
The self-medication hypothesis and psychostimulant treatment of cocaine dependence: an update. Am J Addict (2013) 0.81
The interface between substance abuse and chronic pain management in primary care: a curriculum for medical residents. Subst Abus (2009) 0.80
Improving temporal efficiency of outpatient buprenorphine induction. Am J Addict (2011) 0.80
Thermal relaxation of lithium dendrites. Phys Chem Chem Phys (2015) 0.80
Levetiracetam for the treatment of co-occurring alcohol dependence and anxiety: case series and review. Am J Drug Alcohol Abuse (2008) 0.80
Does remission from alcohol and drug use disorders increase the likelihood of smoking cessation among nicotine dependent young adults? Soc Psychiatry Psychiatr Epidemiol (2008) 0.80
The effects of alcohol and drug dependence on the course of depression. Am J Addict (2006) 0.79
A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients. Am J Addict (2013) 0.79
Do routinely measured risk factors for obesity explain the sex gap in its prevalence? Observations from Saudi Arabia. BMC Public Health (2015) 0.79
Impact of a brief training on medical resident screening for alcohol misuse and illicit drug use. Am J Addict (2008) 0.79
Substance abuse among patients with schizophrenia. J Psychiatr Pract (2002) 0.78
Quetiapine treatment of zolpidem dependence. Am J Addict (2007) 0.78
Comparison of clinical trial recruitment populations: treatment-seeking characteristics of opioid-, cocaine-, and cannabis-using participants. J Subst Abuse Treat (2011) 0.78
The "younger-sibling-at-risk design": a pilot study of adolescents with ADHD and an older sibling with substance use disorder. Am J Drug Alcohol Abuse (2011) 0.78
Comparison of substance use milestones in cannabis- and cocaine-dependent patients. J Addict Dis (2012) 0.78
Open-label pilot study of quetiapine treatment for cannabis dependence. Am J Drug Alcohol Abuse (2014) 0.77
Verbal learning in marijuana users seeking treatment: a comparison between depressed and non-depressed samples. Am J Drug Alcohol Abuse (2014) 0.77